Provident Comm

New Post Public Reply Private Reply Replies (1) Message Board
SaltyMutt
VectorVest Logo
Provident Comm (PCBS)
$0.40
(0.00%)
Thursday, February 14, 2013
PCBS is overvalued compared to its Price of $0.40 per share , has below average safety , and is currently rated a Hold.

Provident Comm (PCBS)


Financial (Savings&Loan)


Company Information

Business: Provident Community Bancshares, Inc. (Provident Community Bancshares) is the bank holding company for Provident Community Bank, N.A. (the Bank). Provident Community Bancshares’ business activity primarily consists of directing the activities of the Bank.

Capital Appreciation

Value: Value is a measure of a stock 's current worth. PCBS has a current Value of $0.33 per share. Therefore, it is overvalued compared to its Price of $0.40 per share. Value is computed from forecasted earnings per share, forecasted earnings growth, profitability, interest, and inflation rates. Value increases when earnings, earnings growth rate and profitability increase, and when interest and inflation rates decrease. VectorVest advocates the purchase of undervalued stocks. At some point in time, a stock 's Price and Value always will converge.

RV (Relative Value): RV is an indicator of long-term price appreciation potential. PCBS has an RV of 0.81, which is poor on a scale of 0.00 to 2.00. This indicator is far superior to a simple comparison of Price and Value because it is computed from an analysis of projected price appreciation three years out, AAA Corporate Bond Rates, and risk. RV solves the riddle of whether it is preferable to buy High growth, High P/E stocks, or Low growth, Low P/E stocks. VectorVest favors the purchase of stocks with RV ratings above 1.00.



VectorVest Testimonials

RS (Relative Safety): RS is an indicator of risk. PCBS has an RS rating of 0.67, which is poor on a scale of 0.00 to 2.00. RS is computed from an analysis of the consistency and predictability of a company 's financial performance, debt to equity ratio, sales volume, business longevity, price volatility and other factors. A stock with an RS rating greater than 1.00 is safer and more predictable than the average stock in the VectorVest database. VectorVest favors the purchase of stocks of companies with consistent, predictable financial performance.

RT (Relative Timing): RT is a fast, smart, accurate indicator of a stock 's price trend. PCBS has a Relative Timing rating of 1.33, which is very good on a scale of 0.00 to 2.00. RT is computed from an analysis of the direction, magnitude, and dynamics of a stock 's price movements over one day, one week, one quarter and one year time periods. Once a stock 's price has established a strong trend, it is expected to continue in that trend for the short-term. If a trend dissipates, RT will gravitate toward 1.00. RT will explode from bottoms, dive from tops, and reflect changes in price momentum. VectorVest favors the purchase of stocks with RT ratings above 1.00.

VST (VST-Vector): VST is the master indicator for ranking every stock in the VectorVest database. PCBS has a VST rating of 1.01, which is fair on a scale of 0.00 to 2.00. VST is computed from the square root of a weighted sum of the squares of RV, RS, and RT. Stocks with the highest VST ratings have the best combinations of Value, Safety and Timing. These are the stocks to own for above average, long-term capital appreciation. VectorVest advocates the purchase of safe, undervalued stocks rising in price.

Recommendation (REC): VectorVest gives a Buy, Sell, Hold recommendation on every stock, every day. PCBS has a Hold recommendation. REC reflects the cumulative effect of all the VectorVest parameters working together. These parameters are designed to help investors buy safe, undervalued stocks rising in price. They also help investors avoid or sell risky, overvalued stocks falling in price. VectorVest recommends that investors buy high VST-Vector, Buy-rated stocks in rising markets.

OR

Stop (Stop-Price): Stop is an indicator of when to sell a long position or cover a short position. PCBS has a Stop of $0.32 per share. This is $0.08 below below PCBS 's current closing Price. A stock 's Stop is computed from a 13 week moving average of its closing prices, and is fine-tuned according to the stock 's fundamentals. High RV, high RS stocks have lower Stops, and low RV, low RS stocks have higher Stops. In the VectorVest system, a stock gets a 'B ' or 'H ' recommendation if its Price is above its Stop and an 'S ' recommendation if its Price is below its Stop.

GRT (Earnings Growth Rate): GRT reflects a company 's one to three year forecasted earnings growth rate in percent per year. PCBS has a forecasted Earnings Growth Rate of 5.00%, which VectorVest considers to be fair. GRT is computed from historical, current and forecasted earnings data. It is updated each week for every stock in the VectorVest database. GRT often foretells a stock 's future price trend. If a stock 's GRT trend is upward, the stock 's price will likely rise. If GRT is trending downward, the stock 's Price will probably fall. VectorVest favors the purchase of stocks whose GRT is rising and is greater than the sum of current inflation and interest rates, as shown weekly in our investment climate report.

EPS (Earnings per Share): EPS stands for leading 12 months Earnings Per Share. PCBS has a forecasted EPS of $-0.36 per share. VectorVest determines this forecast from a combination of recent earnings performance and traditional fiscal and/or calendar year earnings forecasts.

P/E (Price to Earnings Ratio): P/E is a popular measure of stock valuation which shows the dollars required to buy one dollar of earnings. PCBS has a P/E of -1.11. This ratio may be deemed to be high or low depending upon your frame of reference. The average P/E of all the stocks in the VectorVest database is 39.49. P/E is computed daily using the formula: P/E = Price/EPS.

EY (Earnings Yield): EY reflects earnings per share as a percent of Price. EY is related to P/E via the formula, EY = 100 / (P/E), and may be used in place of P/E as a measure of valuation. EY has the advantages that it is always determinate and can reflect negative earnings. PCBS has an EY of -90.00 percent. This is below the current average of 2.52% for all the stocks in the VectorVest database. EY equals 100 x (EPS/Price).

GPE (Growth to P/E Ratio): GPE is another popular measure of stock valuation. It compares earnings growth rate to P/E ratio. PCBS has a GPE rating of -4.49. High growth stocks are believed to be able to justify high P/E ratios. A stock is commonly considered to be undervalued when GPE is greater than 1.00 and overvalued when GPE is below 1.00. Unfortunately, this rule of thumb does not take into account the effect of interest rates on P/E ratios. The operative GPE ratio of 1.00 is valid when and only when interest rates equal 10%. With long-term interest rates currently at 2.63%, the operative GPE ratio is 0.07. Therefore, PCBS may be considered to be overvalued.

Dividend Information

DIV (Dividend): VectorVest reports annual, regular, cash dividends as indicated by the most recent payments. Special distributions, one-time payments, stock dividends, etc., are not generally included in DIV. PCBS does not pay a dividend.

DY (Dividend Yield): DY reflects dividend per share as a percent of Price. PCBS does not pay a dividend, so it does not have a Dividend Yield rating . DY equals 100 x (DIV/Price). It is useful to compare DY with EY. If DY is not significantly lower than EY, the dividend payment may be in jeopardy.

DS (Dividend Safety): DS is an indicator of the assurance that regular cash dividends will be declared and paid at current or at higher rates for the foreseeable future. PCBS does not pay a dividend, so it does not have a Dividend Safety rating . Stocks with DS values above 75 typically have RS values well above 1.00 and EY levels that are much higher than DY.

DG (Dividend Growth Rate): Dividend Growth is a subtle yet important indicator of a company 's financial performance. It also provides some insight into the board 's outlook on the company 's ability to increase earnings. PCBS does not pay a dividend, so it does not have a Dividend Growth rating .

YSG (YSG-Vector): YSG is an indicator which combines DIV, DY and DG into a single value, and allows direct comparison of all dividend-paying stocks in the database. PCBS does not pay a dividend, so it does not have a YSG rating which is . Stocks with the highest YSG values have the best combinations of Dividend Yield, Safety and Growth. These are the stocks to buy for below current income and long-term growth.

Price-Volume Data

Price: PCBS closed on Thursday, February 14, 2013 at $0.40 per share.

Open: PCBS opened trading at a price of $0.40 per share on Thursday, February 14, 2013.

High: PCBS traded at a High price of $0.40 per share on Thursday, February 14, 2013.

Low: PCBS traded at a Low price of $0.40 per share on Thursday, February 14, 2013.

Close: PCBS closed on Thursday, February 14, 2013 at $0.40 per share. (Close is also called Price in the VectorVest system)

Range: Range reflects the difference between the High and Low prices for the day. PCBS traded with a range of $0.00 per share on Thursday, February 14, 2013.

$ Change: PCBS unchanged from the prior day 's closing Price.

%PRC: PCBS 's Price changed 0.00% from the prior day 's closing price.

Volume: PCBS traded 0 shares on Thursday, February 14, 2013.

AvgVol: AvgVol is the 50 day moving average of daily volume as computed by VectorVest. PCBS has an AvgVol of 402 shares traded per day.

%Vol: %Vol reflects the percent change in today 's trading volume as compared to the AvgVol. %Vol equals ((Volume - AvgVol) / AvgVol ) * 100. PCBS had a %Vol of -100.00% on Thursday, February 14, 2013

CI (Comfort Index): CI is an indicator which reflects a stock 's ability to resist severe and/or lengthy price declines. PCBS has a CI rating of 0.84, which is poor on a scale of 0.00 to 2.00. CI is quite different from RS in that it is based solely upon a stock 's long-term price history. VectorVest advocates the purchase of high CI stocks.

Sales / Market Capitalization Information

Sales: PCBS has annual sales of 12,000,000

Sales Growth: Sales Growth is the Sales Growth Rate in percent over the last 12 months. PCBS has a Sales Growth of -7.00% per year. This is very poor. Sales Growth is updated each week for every stock. It is often useful to compare Sales Growth to Earnings Growth to gain an insight into a company 's operations.

Sales Per Share (SPS): PCBS has annual sales of $6.99 per share. SPS can be used as a measure of valuation when comparing stocks within an Industry Group.

Price to Sales Ratio (P/S): PCBS has a P/S of 0.06. This ratio is also used as a measure of valuation. Here, too, it is useful when comparing stocks within an Industry Group.

Shares: PCBS has 1,000,000 shares of stock outstanding.

Market Capitalization: PCBS has a Market Capitalization of 0. Market Capitalization is calculated by multiplying price times shares outstanding.

Business Sector: PCBS has been assigned to the Financial Business Sector. VectorVest classifies stocks into over 200 Industry Groups and 40 Business Sectors.

Industry Group: PCBS has been assigned to the Financial (Savings&Loan) Industry Group. VectorVest classifies stocks into over 200 Industry Groups and 40 Business Sectors.

For another stock analysis, please click here.

Please do not reply to this email. For answers to your questions, please call 1-888-658-7638, or email us at support@vectorvest.com .

Copyright 2010 by VectorVest, Inc. All Rights Reserved.
20472 Chartwell Center Drive, Cornelius NC 28031
For additional information, call 1-888-658-7638, e-mail to support@vectorvest.com ,
or visit our internet site at http://www.vectorvest.com

For international phone numbers please click here.

DISCLAIMER: VectorVest is licensed by VectorVest, Inc., and is protected by United States copyright laws and international treaty provisions. The information contained herein is for your exclusive, personal use only. You may print a single copy of any stock analysis for your exclusive use, but it is not to be reproduced for distribution without the expressed written consent of VectorVest, Inc. You should be aware of the risks involved in stock investing, and you use the material contained herein at your own risk. This material is believed to be reliable, but neither VectorVest, Inc., nor any of its suppliers guarantee its accuracy or validity, nor are they responsible for any errors or omissions which may have occurred. The analysis, ratings, and/or recommendations made by VectorVest, and/or any of its suppliers do not provide, imply, or otherwise constitute a guarantee of performance.

VectorVest is comprised of reports embodying a unique system of stock analysis. All contents and recommendations are based on data and sources believed to be reliable, but accuracy and completeness cannot be guaranteed. Users should be aware of the risks involved in stock investments. It should not be assumed that future results will be profitable or will equal past performance, real, indicated or implied. VectorVest and/or its principals may purchase or sell any of the securities cited herein. VectorVest and the logostyle, geometric design are, individually and collectively, service marks owned by VectorVest, Inc. VectorVest is published daily by VectorVest, Inc. 20472 Chartwell Center Drive Cornelius, NC 28031 704-895-4095

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Austin PostalAnnex Changes Hands After 19 Years

Updated Category News Views 3

A Seamless Transition in Austin's PostalAnnex Legacy You know when a business digs its roots deep, becoming more than just a place but a part of the community fabric? That's what’s playing out at the PostalAnnex on W Parmer Lane, Austin. After nearly two decades, this battered yet steadfast hub of office and shipping services is swapping hands, all in the name of...

Continue Reading
India's First Upright Proton Therapy System Unveiled

Updated Category News Views 6

A Leap Forward in Cancer Care: Proton Therapy Revolution Dang, just when you think you've heard it all in cancer treatment, Fortis Healthcare drops a bombshell: India’s first upright proton therapy system. Boom! This isn't your run-of-the-mill radiation treatment we're talking about here. This is the futuristic flair of the MEVION S250-FIT™, featuring upright...

Continue Reading
Spot the Signs: Early Gum Disease Insights from Experts

Updated Category News Views 2

Why Early Detection of Gum Disease Matters Let's dive right into the crux of things. Gum disease, that sneaky antagonist of oral health, starts unassumingly. You brush, you floss, but those gums might still bleed—ever noticed? Dr. Marian Burgard of Fairport Family Dental has a thing or two to say about this, enlightening us through an insightful piece by HelloNation....

Continue Reading
Leidos' Autonomous Vessels Chart Bold Naval Waters

Updated Category News Views 1

Leidos' Autonomous Leap with the U.S. Navy Well, today it's all about Leidos, an outfit that's been showing its grit in the world of maritime autonomy. Their systems aren't just tinkering around anymore—they're slicing through the waves at RIMPAC, the Rim of the Pacific, and running alongside the USS Theodore Roosevelt Carrier Strike Group. That's big news in anyone's...

Continue Reading
Intellectia.AI Transforming Trading with AI Upgrades

Updated Category News Views 2

Intellectia.AI Sparks New Trading Era Intellectia.AI, from the bustling streets of New York, is cutting through the noise with a flashy update to its AI-powered trading setup. They've thrown a heap of new toys into the ring, letting folks piggyback on high-grade stock moves in the blink of an eye. Gone are the days of fumbling with cumbersome data and execution. Breaking...

Continue Reading
Life Flower Celebrates 16 Years with Dog Adoption Event

Updated Category News Views 3

A Celebration with Heart Ah, the classic mix of business and community goodwill—that's what Life Flower Dispensary is all about this year. You know, not every business that hits the 16-year mark decides to make it about something bigger than just slashing prices or hyping themselves up. But Life Flower? They're using their anniversary to throw a shindig that's more than...

Continue Reading
Tiger Group to Auction Huge Window Manufacturing Plant

Updated Category News Views 5

Glass & Vinyl Ambitions: A New Chapter Who would have guessed? The seasoned window maker Showcase Window and Door Company is putting its prime manufacturing facility up for grabs. The online auction, orchestrated by Tiger Group, kicks off September 10, and it's sure to stir up some excitement in the industry. With picking up operations now within reach, it feels like...

Continue Reading
BrightPlan's AI-Powered Growth: Series C Fuel

Updated Category News Views 5

Series C Funding Ignites BrightPlan's Ambitions Ever seen a company that's ready to roll with the punches and come out stronger? That's BrightPlan for you. They're pushing the boundaries again, bagging new capital in this Series C round, steered by the seasoned folks over at ABS Capital Partners. Now, here's the thing: We're talking about a 230% revenue surge over just...

Continue Reading
Illinois' Legal Tangle: Feds Under Fire?

Updated Category News Views 2

What a tangled web Illinois lawmakers have woven this time. They've gone and cooked up a pair of laws with a real knack for attracting attention—specifically from the folks over at the National Police Association (NPA). These aren’t your run-of-the-mill rules; they feel more like a blueprint for putting federal officers through the legal wringer and turning courtroom...

Continue Reading
Drunk Angel Celebrates First Year in Crystal Jewelry

Updated Category News Views 3

One Year Down, A Unique Path Forward It's been a year since Drunk Angel jumped into the online jewelry scene, and they're setting themselves apart in their own glittery lane. Imagine starting a brand that's not just about pretty trinkets, but about linking those tiny treasures to timeless traditions. They've got their sights set on blending the deep tales of gemstones...

Continue Reading

Top 5 Most Recently Viewed Articles

Primax & Qualcomm Edge AI: Reshaping Meetings

Updated Category News Views 7

Enhanced AI Driven Conferencing: Welcome to 2026 Primax Electronics is firing on all cylinders. Those folks are pretty intent on reshaping the digital meeting landscape with their new AI conference solutions, a move that aligns with the rapidly changing nature of business interactions. And let me tell you, there’s more here than meets the eye—for Primax, the shift...

Continue Reading
USD Partners Moves Toward Final Asset Sale with Future Plans

Updated Category News Views 185

USD Partners LP Anticipates Sale of Key Asset USD Partners LP (OTC: USDP) has announced that it is set to complete the sale of its Hardisty Rail Terminal, which stands as its last operational asset. This significant step comes as a requirement imposed by its lending institutions associated with the revolving credit facility. The partnership has carefully navigated a path...

Continue Reading
AUD/USD Faces Uphill Battle as Economic Factors Shift

Updated Category News Views 77

AUD/USD Faces Uphill Battle as Economic Factors Shift The AUD/USD currency pair is presently navigating turbulent waters, trying to inch closer to 0.6681. However, this attempt at recovery presents a tricky scenario as it lingers near a six-week low. The US dollar's ascent, coupled with rising US Treasury yields, is largely fueled by speculations surrounding a favorable...

Continue Reading
Unraveling the Impact of Rare Earth Metals in Industries

Updated Category News Views 146

Understanding the Rare Earth Metals Market The global market for rare earth metals is witnessing a significant transformation, projected to reach an impressive USD 7,386.3 million by 2030. This projection stems from growing demand across various high-tech sectors, including clean energy, electronics, and defense technologies. In 2024, the market was valued at USD 5,139.1...

Continue Reading
Growing Opportunities in the U.S. Drug Screening Market

Updated Category News Views 162

Revolutionizing Drug Testing in the U.S. The U.S. drug screening market has been gaining significant momentum, projected to expand from its current value of USD 2.70 billion to an impressive USD 3.84 billion by 2034. This represents a compound annual growth rate (CAGR) of approximately 3.64%. The rise in market demand can be attributed to various factors, including...

Continue Reading